References

• Lindstrom S, Garten R, Balish A, et al. Human infections with novel reassortant influenza A(H3N2)v viruses, United States, 2011. Emerg Infect Dis 2012;18:834-7.
• CDC. Update: influenza A (H3N2)v transmission and guidelines-five states, 2011. MMWR 2012;60:1741-4.
• CDC. Notes from the field: outbreak of influenza A (H3N2) virus among persons and swine at a county fair-Indiana, July 2012. MMWR 2012;61:561.
• CDC. Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of 2010-11 seasonal influenza vaccine on cross-reactive antibodies-United States. MMWR 2012;61:237-41.
• CDC. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2011;60(No. RR-1).
• Hurt AC, Alexander R, Hibbert J, Deed N, Barr IG. Performance of six influenza rapid tests in detecting human influenza in clinical specimens. J Clin Virol 2007;39:132-5.
• Faix DJ, Sherman SS, Waterman SH. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;361:728-9.
• Ginocchio CC, Zhang F, Manji R, et al. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 2009;45:191-5.
• Uyeki TM, Prasad R, Vukotich C, et al. Low sensitivity of rapid diagnostic test for influenza. Clin Infect Dis 2009;48:e89-92.
• CDC. Guidance for clinicians on the use of rapid influenza diagnostic tests. Atlanta, GA: US Department of Health and Human Services, CDC; 2011. Available at ＜http://www.cdc.gov/flu/professionals/ diagnosis/clinician_guidance_ridt.htm＞. Accessed August 9, 2012